Clinical trials
Completed Muscular Atrophy trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
152 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 8 |
| 2017 | 14 |
| 2018 | 12 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 15 |
| 2023 | 15 |
| 2024 | 8 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 152 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 7 |
| McMaster University | 5 |
| United States Army Research Institute of Environmental Medicine | 5 |
| Bispebjerg Hospital | 4 |
| National Yang Ming Chiao Tung University | 4 |
| DLR German Aerospace Center | 3 |
| McGill University | 3 |
| Tufts University | 3 |
| University of Birmingham | 3 |
| University of Exeter | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy | 152 |
| Sarcopenia | 24 |
| Muscle Weakness | 15 |
| Critical Illness | 10 |
| Frailty | 7 |
| Muscular Disorders, Atrophic | 6 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Weight Loss | 5 |
| Bone Diseases, Metabolic | 4 |
| Fatigue | 4 |
Trials
Showing 1 to 25 of 152. Each trial links to its page on Pharma Observatory.
52 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.